MA insider: 17,816 options exercised and sold; 10b5-1 plan used
Rhea-AI Filing Summary
Sachin J. Mehra, Chief Financial Officer of Mastercard Inc. (MA), reported Option exercise and share sales on 08/19/2025 executed under a pre-planned Rule 10b5-1 trading plan adopted May 5, 2025. The report shows Mehra exercised 17,816 employee stock options with an exercise price of $239.05, generating 17,816 Class A shares. Those 17,816 shares were sold in multiple transactions at weighted-average prices ranging from $584.45 to $590.50, reflected as several sales reducing his beneficial ownership from 49,049.597 shares to 31,233.597 shares. The exercised options were awarded April 1, 2019 and are exercisable through March 1, 2029. The Form 4 is signed by an attorney-in-fact on behalf of Mehra on 08/20/2025.
Positive
- Trades executed under a Rule 10b5-1 trading plan, indicating pre-planned, compliance-oriented transactions
- Options exercised were previously vested (awarded April 1, 2019), so exercise was not an acceleration or special grant
Negative
- Reporting person sold all shares acquired from the option exercise (17,816 shares were sold), reducing beneficial ownership
- Significant share disposals occurred at market prices, which could be viewed as a liquidity event for the insider
Insights
TL;DR: CFO exercised vested options and sold the resulting shares under a 10b5-1 plan, reducing his Class A holding by 17,816 shares.
The filing documents a routine exercise of vested employee stock options (17,816 options at $239.05) followed by contemporaneous sales that fully dispositioned the acquired shares. Sales were executed in tranches with weighted-average prices reported between $584.45 and $590.50, reducing beneficial holdings from 49,049.597 to 31,233.597 shares. The use of a Rule 10b5-1 plan (adopted May 5, 2025) indicates the trades were pre-planned for personal financial management and intended to satisfy affirmative-defense conditions.
TL;DR: The transaction follows established insider-trading compliance: exercise of vested options and sales executed under a documented 10b5-1 plan.
The report discloses that the reporting person exercised previously vested options (awarded April 1, 2019) and then sold the acquired shares in multiple tranches. The disclosure of weighted-average sale prices and the 10b5-1 adoption date provides transparency consistent with good governance practices. The Form 4 was executed by an attorney-in-fact, as documented on the filing.